Durham, NC, United States of America

Tracy Gentry


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Tracy Gentry

Introduction

Tracy Gentry is a notable inventor based in Durham, NC (US), recognized for his significant contributions to the field of stem cell research. With a total of 3 patents, Gentry has focused on innovative methods that enhance the understanding and application of stem cell populations in medical treatments.

Latest Patents

Gentry's latest patents include groundbreaking inventions that address critical health issues. One of his patents, titled "Stem cell populations and methods of use," relates to populations of stem cells and methods for isolating these cells. This invention also encompasses techniques for repairing, regenerating, and reconstituting tissues using these stem cell populations. Another significant patent is "Treating amyotrophic lateral sclerosis (ALS) with isolated aldehyde dehydrogenase-positive umbilical cord blood cells." This method involves treating patients with neurodegenerative diseases, such as ALS, using progenitor cells isolated from human umbilical cord blood. The non-invasive transplantation of these cells provides cell replacement and protection of motor neurons.

Career Highlights

Throughout his career, Gentry has worked with prominent organizations, including Aldagen, Inc. and the University of South Florida. His work in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Gentry has collaborated with various professionals in his field, including Andrew E. Balber and Sandra J. Foster. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Tracy Gentry's innovative work in stem cell research has led to significant advancements in medical treatments for neurodegenerative diseases. His patents reflect a commitment to improving patient care through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…